Ro has 3 close competitors: Alma, Devoted Health, Virta Health.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Alma
Devoted Health
Virta HealthAmerican telehealth company (Roman Health Ventures Inc., trading as Ro) that diagnoses patients and prescribes and delivers treatments and ongoing care, providing pricing exposure through Canborsa.
Ro competes with 3 companies here: Alma, Devoted Health, Virta Health.
Ro was last valued at $5B (post-money, Mar 2021). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Ro is a private company; its shares do not trade on a public exchange.
The last valuation is $5B.
Lead investors for each round are in the funding timeline.
The closest telehealth peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
